EIF2AK4 and pulmonary venoocclusive disease: Histopathology of EIF2AK4 mutation carriers in pulmonary veno-occlusive disease (PVOD) patients was distinctive from noncarriers regarding arterial remodeling, with significantly more severe intimal fibrosis and less severe medial hypertrophy (Nossent et al., 2018).